Skip to main content

Advertisement

Log in

Variation over time of the factors influencing return to work and work capacities after a diagnosis of breast cancer: a study on the behalf of the Seintinelles research network

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the dynamics of the determinants of returning to work (RTW) in a population of patients treated for breast cancer (BC) in a real-world setting.

Method

We conducted a retrospective study including 1278 BC patients working or looking for work at the time of diagnosis. We performed a focused principal component analysis to highlight the dimensions of a persistent decline in work capacity. Logistic regression analyses were performed to identify correlates of non-RTW 1 and 2 years after treatment.

Results

One-third (31%, n = 389) of patients continued working during treatment. At study inclusion, 1100 patients had returned to work (89%). Three-quarters (n = 508, 75%) of the women reported a decline in work capacity 1 year after RTW and 22% (n = 148) presented a persistent decline in work capacity 2 years after the diagnosis. The odds ratio for non-RTW at 1 year was significantly higher for patients treated with a combination of chemotherapy and trastuzumab (OR = 1.72, 95% CI [1.07–2.76]), manual workers (OR = 3.99, 95% CI [1.54–10.81]), patients with lower incomes (OR = 2.33, 95% CI [1.29–4.19]), and patients experiencing fatigue (OR = 1.81, 95% CI [1.34–2.48]). The odds ratio for non-RTW at 2 years was higher for various occupational categories (OR = 3.49, 95% CI [1.89–6.74] for clerks, OR = 4.58, 95% CI [1.48–12.82] for self-employed workers, OR = 8.98, 95% CI [2.69–27.89] for manual workers), patients with comorbidities (OR = 2.80, 95% CI [1.61–4.93]), and patients experiencing anxiety symptoms (OR = 2.54, 95% CI [1.18–5.76]), while the impact of the type of treatment was no longer significantly associated with RTW.

Conclusion

The determinants of RTW change over time. Patients should be offered supportive interventions tailored to risk factors and time from diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data Availability

The use of data is restricted by the French regulations which gave their consent for this study. Data may be requested on a case-by-case basis by contacting the corresponding author.

Code availability

R software.

References

  1. Arfi A, Baffert S, Soilly AL, Huchon C, Reyal F, Asselain B, Neffati S, Rouzier R, Héquet D (2018) Determinants of return at work of breast cancer patients: results from the OPTISOINS01 French prospective study. BMJ Open. 8(5):e020276

    PubMed  PubMed Central  Google Scholar 

  2. Dumas A, Vaz Luis I, Bovagnet T, El Mouhebb M, Di Meglio A, Pinto S, Charles C, Dauchy S, Delaloge S, Arveux P, Coutant C, Cottu P, Lesur A, Lerebours F, Tredan O, Vanlemmens L, Levy C, Lemonnier J, Mesleard C, Andre F, Menvielle G (2019) Impact of breast cancer treatment on employment: results of a multicenter prospective cohort study (CANTO). J Clin Oncol JCO1901726

  3. Bouhnik AD, Bendiane MK, Cortaredona S, Sagaon Teyssier L, Rey D, Berenger C, Seror V, Peretti-Watel P; members of VICAN Group (2015) The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the VICAN survey). BMJ Open 5(3)

  4. Institut National du Cancer. Le cancer du sein en chiffres. https://www.e-cancer.fr/Professionnels-de-sante/Les-chiffres-du-cancer-en-France/Epidemiologie-des-cancers/Les-cancers-les-plus-frequents/Cancer-du-sein. Last visited 23rd November 2020

  5. VICAN 5, La vie cinq ans après un cancer. https://www.e-cancer.fr/Presse/Dossiers-et-communiques-de-presse/Cinq-ans-apres-un-diagnostic-de-cancer-la-qualite-de-vie-et-la-situation-en-emploi-restent-fortement-degrades. Last visited 23rd November 2020

  6. Sevellec M, Belin L, Bourrillon MF, Lhuilier D, Rérolle E, Le Bideau S, Cotasson-Guillet F, Le Peltier N, Asselain B (2015) Work ability in cancer patients: six years assessment after diagnosis in a cohort of 153 workers. Bull Cancer 102(6 Suppl 1):S5-13

    Article  Google Scholar 

  7. Héquet D, Huchon C, Soilly AL, Asselain B, Berseneff H, Trichot C, Combes A, Alves K, Nguyen T, Rouzier R, Baffert S (2019) Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: results of a French multicenter prospective study. PLoS One 14(7):e0210917

    Article  Google Scholar 

  8. Van Muijen P, Weevers NL, Snels IA, Duijts SF, Bruinvels DJ, Schellart AJ, van der Beek AJ (2013) Predictors of return to work and employment in cancer survivors: a systematic review. Eur J Cancer Care (Engl) 22:114–160

    Google Scholar 

  9. Taskila-Brandt T, Martikainen R, Virtanen SV, Pukkala E, Hietanen P, Lindbohm ML (2009) The impact of education and occupation on the employment status of cancer survivors. Eur J Cancer 40:2488–2493

    Article  Google Scholar 

  10. Ahn E, Cho J, Shin DW, Park BW, Ahn SH, Noh DY, Nam SJ, Lee ES, Yun YH (2009) Impact of breast cancer diagnosis and treatment on work-related life and factors affecting them. Breast Cancer Res Treat 116:609–616

    Article  Google Scholar 

  11. Cooper AF, Hankins M, Rixon L, Eaton E, Grunfeld EA (2012) Distinct work-related, clinical and psychological factors predict return to work following treatment in four different cancer types. Psychooncology 22:659–667

    Article  Google Scholar 

  12. Islam T, Dahlui M, Majid HA, Nahar AM, Mohd Taib NA, Su TT; MyBCC study group (2014) Factors associated with return to work of breast cancer survivors: a systematic review. BMC Public Health 14 (Suppl 3):S8

  13. Bauquier C, Pannard M, Préau M (2017) The Seintinelles: an innovative approach to promoting Community-Based Research and sustaining health democracy in oncology. Sante Publique 29(4):547–550

    Article  Google Scholar 

  14. LeBlanc TW, Abernethy AP. Patient-reported outcomes in cancer care - hearing the patient voice at greater volume [published online October 4, 2017]. Nat Rev Clin Oncol

  15. von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, Jacot W, Conlin AK, Arce-Salinas C, Wapnir IL, Jackisch C, DiGiovanna MP, Fasching PA, Crown JP, Wülfing P, Shao Z, Rota Caremoli E, Wu H, Lam LH, Tesarowski D, Smitt M, Douthwaite H, Singel SM, Geyer CE Jr, KATHERINE Investigators (2019) Trastuzumab emtansine for residual invasive HER2-positive breast cancer. N Engl J Med 380(7):617–628

  16. Masuda N, Lee SJ, Ohtani S, Im YH, Lee ES, Yokota I, Kuroi K, Im SA, Park BW, Kim SB, Yanagita Y, Ohno S, Takao S, Aogi K, Iwata H, Jeong J, Kim A, Park KH, Sasano H, Ohashi Y, Toi M (2017) Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med 376(22):2147–2159

    Article  CAS  Google Scholar 

  17. Bellagamba G, Descamps A, Cypowyj C, Eisinger F, Villa A, Lehucher-Michel MP (2021) Cancer survivors’ efforts to facilitate return to work. Psychol Health Med 26(7):845–852

    Article  Google Scholar 

  18. Guo YJ, Tang J, Li JM, Zhu LL, Xu JS (2021) Exploration of interventions to enhance return-to-work for cancer patients: a scoping review. Clin Rehabil 35(12):1674–1693

    Article  Google Scholar 

  19. Hatton R, Wallis A, Chew A, Stanley M, Smith A (2021) Return to work and cancer: perspectives of occupational therapists. Aust Occup Ther J. 68(4):298–307

    Article  Google Scholar 

  20. de Boer AG, Taskila TK, Tamminga SJ, Feuerstein M, Frings-Dresen MH, Verbeek JH (2015) Interventions to enhance return-to-work for cancer patients. Cochrane Database Syst Rev. 2015(9):CD007569

    PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the Seintinelles cancer network.

Author information

Authors and Affiliations

Authors

Contributions

Delphine Hequet: conceptualization, methodology, formal analysis, writing—original draft, writing—review and editing

Anne-Sophie Hamy: conceptualization, validation, writing—review and editing

Noemie Girard: formal analysis

Enora Laas: writing—review and editing

Florence Coussy: writing—review and editing

Roman Rouzier: writing—review and editing

Marie Preau: conceptualization, methodology, funding acquisition

Lidia Delrieu: conceptualization, methodology, funding acquisition

Agnes Dumas: conceptualization, methodology, funding acquisition

Fabien Reyal: conceptualization, methodology, funding acquisition

Corresponding author

Correspondence to Delphine Hequet.

Ethics declarations

Ethics approval

This study was approved by our ethics committee.

Consent to participate

All the patients in the study gave their consent to participate by completing the online questionnaire.

Consent for publication

NA

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hequet, D., Hamy, AS., Girard, N. et al. Variation over time of the factors influencing return to work and work capacities after a diagnosis of breast cancer: a study on the behalf of the Seintinelles research network. Support Care Cancer 30, 5991–5999 (2022). https://doi.org/10.1007/s00520-022-07000-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-022-07000-x

Keywords

Navigation